"Missing mutations" in MPS I: Identification of two novel copy number variations by an IDUA-specific in house MLPA assay.
IDUA
MLPA
copy number variations
deletion
duplication
Journal
Molecular genetics & genomic medicine
ISSN: 2324-9269
Titre abrégé: Mol Genet Genomic Med
Pays: United States
ID NLM: 101603758
Informations de publication
Date de publication:
09 2019
09 2019
Historique:
received:
14
12
2018
revised:
06
02
2019
accepted:
11
02
2019
pubmed:
19
7
2019
medline:
18
6
2020
entrez:
19
7
2019
Statut:
ppublish
Résumé
Mucopolysaccharidosis type I (MPS I) is a rare, recessively inherited lysosomal storage disorder, characterized by progressive multi-systemic disease. It is caused by a reduced or absent alpha-l iduronidase (IDUA) enzyme activity secondary to biallelic loss-of-function variants in the IDUA. Over 200 causative variants in IDUA have been identified. Nevertheless, there is a fraction of MPS I patients with only a single mutated IDUA allele detectable. As genetic testing of MPS I is usually based on sequencing methods, copy number variations (CNVs) in IDUA can be missed and therefore presumably remain underdiagnosed. The aim of this study was the detection of CNVs using an IDUA-specific in house multiplex ligation-dependent probe amplification (MLPA) assay. A total of five unrelated MPS I patient samples were re-analyzed after only a single heterozygous IDUA mutation c.979G>C (p.A327P), c.1469T>C (p.L490P), c.1598C>G (p.P533R), c.1205G>A (p.W402X), c.973-7C>G (p.?) could be identified. We detected a novel splice site variant c.973-7C>G (p.?), as well as two novel CNVs, a large deletion of IDUA exon 14 and 3'UTR c.(1828 + 1_1829-1)_(*1963_?)del, and a large duplication extending from IDUA exon 2 to intron 12 c.(157 + 1_158-1)_(1727 + 1_1728-1)dup. Together with the CNVs we previously identified, a total of four pathogenic IDUA CNVs have now been reported.
Sections du résumé
BACKGROUND
Mucopolysaccharidosis type I (MPS I) is a rare, recessively inherited lysosomal storage disorder, characterized by progressive multi-systemic disease. It is caused by a reduced or absent alpha-l iduronidase (IDUA) enzyme activity secondary to biallelic loss-of-function variants in the IDUA. Over 200 causative variants in IDUA have been identified. Nevertheless, there is a fraction of MPS I patients with only a single mutated IDUA allele detectable.
METHODS
As genetic testing of MPS I is usually based on sequencing methods, copy number variations (CNVs) in IDUA can be missed and therefore presumably remain underdiagnosed. The aim of this study was the detection of CNVs using an IDUA-specific in house multiplex ligation-dependent probe amplification (MLPA) assay.
RESULTS
A total of five unrelated MPS I patient samples were re-analyzed after only a single heterozygous IDUA mutation c.979G>C (p.A327P), c.1469T>C (p.L490P), c.1598C>G (p.P533R), c.1205G>A (p.W402X), c.973-7C>G (p.?) could be identified. We detected a novel splice site variant c.973-7C>G (p.?), as well as two novel CNVs, a large deletion of IDUA exon 14 and 3'UTR c.(1828 + 1_1829-1)_(*1963_?)del, and a large duplication extending from IDUA exon 2 to intron 12 c.(157 + 1_158-1)_(1727 + 1_1728-1)dup.
CONCLUSION
Together with the CNVs we previously identified, a total of four pathogenic IDUA CNVs have now been reported.
Identifiants
pubmed: 31319022
doi: 10.1002/mgg3.615
pmc: PMC6732313
doi:
Substances chimiques
IDUA protein, human
EC 3.2.1.76
Iduronidase
EC 3.2.1.76
Types de publication
Clinical Trial
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e00615Informations de copyright
© 2019 The Authors. Molecular Genetics & Genomic Medicine published by Wiley Periodicals, Inc.
Références
Hum Mutat. 1992;1(2):103-8
pubmed: 1301196
Trends Biochem Sci. 1998 Jun;23(6):198-9
pubmed: 9644970
Acta Paediatr. 1995 Mar;84(3):337-9
pubmed: 7780260
Am J Hum Genet. 1993 Nov;53(5):973-86
pubmed: 8213840
Biochim Biophys Acta. 1998 Sep 30;1407(3):249-56
pubmed: 9748610
Mol Genet Genomic Med. 2019 Sep;7(9):e00615
pubmed: 31319022
Hum Mutat. 2017 Nov;38(11):1555-1568
pubmed: 28752568
Hum Mol Genet. 1994 Jun;3(6):861-6
pubmed: 7951228
Clin Genet. 2018 Jul;94(1):95-102
pubmed: 29393969
Hum Mutat. 2016 Jul;37(7):703-9
pubmed: 27071356
Clin Genet. 2016 Dec;90(6):496-508
pubmed: 27146977
Hum Mutat. 1992;1(4):333-9
pubmed: 1301941
Hum Genet. 2001 Nov;109(5):503-11
pubmed: 11735025
Hum Genome Var. 2016 Oct 06;3:16031
pubmed: 27766162
Am J Hum Genet. 1990 Nov;47(5):802-7
pubmed: 2220820
Am J Med Genet A. 2009 May;149A(5):965-74
pubmed: 19396826
Hum Mutat. 1995;6(4):288-302
pubmed: 8680403
Hum Genomics. 2011 May;5(4):241-64
pubmed: 21712188
Am J Hum Genet. 2016 Apr 7;98(4):597-614
pubmed: 27040688
Hum Mutat. 2011 Jun;32(6):E2189-210
pubmed: 21394825
Hum Mutat. 1995;6(1):55-9
pubmed: 7550232
Genet Med. 2014 Oct;16(10):759-65
pubmed: 24675674